Cochrane Abstracts
Galactomannan detection for invasive aspergillosis in immunocompromised patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Galactomannan Detection for Invasive Aspergillosis in Immunocompromised Patients." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435910/all/Galactomannan_detection_for_invasive_aspergillosis_in_immunocompromised_patients.
Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435910/all/Galactomannan_detection_for_invasive_aspergillosis_in_immunocompromised_patients. Accessed May 9, 2025.
Galactomannan detection for invasive aspergillosis in immunocompromised patients. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435910/all/Galactomannan_detection_for_invasive_aspergillosis_in_immunocompromised_patients
Galactomannan Detection for Invasive Aspergillosis in Immunocompromised Patients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435910/all/Galactomannan_detection_for_invasive_aspergillosis_in_immunocompromised_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Galactomannan detection for invasive aspergillosis in immunocompromised patients
ID - 435910
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435910/all/Galactomannan_detection_for_invasive_aspergillosis_in_immunocompromised_patients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
